About
Technology
Issues
FAQ
Links
Official Page
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.